Foundation for Mitochondrial Medicine


Foundation for Mitochondrial Medicine

Moving the Dial for Pediatric Mitochondrial Disease Patients

Dr. Leon Dure Leads Pediatric Mitochondrial Care at the University of Alabama at Birmingham

The Foundation for Mitochondrial Medicine (FMM) is pleased to announce that through its partnership with the University of Alabama at Birmingham (UAB), Dr. Leon Dure is leading a new pediatric mitochondrial disease clinical care program at UAB. In addition to addressing the clinical needs of patients in the Southeast, there will be future opportunities for patients to participate in exciting new bioenergetics research which involves the measure of mitochondrial function via a non-invasive blood test. This test could potentially serve as an objective measure of fatigue, measure the efficacy of an intervention and possibly replace muscle biopsies often used to diagnose mitochondrial diseases. To learn more click Science on the Horizon.

The clinical and research components address unmet clinical, diagnostic and therapeutic needs of the pediatric mitochondrial patient community. Dr. Dure, Professor and Director of the Division of Pediatric Neurology, holds the William Bew White, Jr. Chair in Pediatric Neurology. Dr. Dure received his medical degree from Baylor College of Medicine with additional training at Babies Hospital/Columbia Presbyterian Medical Center and College of Physicians and Surgeons and the University of Michigan. Dr. Dure’s clinical research interests are movement disorders in childhood as well as Huntington’s Disease.

“We are delighted to refer FMM families and friends to Dr. Dure,” said Laura Stanley, executive director of FMM. “He is one of the Southeast’s leading pediatric neurologists, and Dr. Dure is eager to begin seeing patients and hopes to help many families with children that have mitochondrial disease.”

To Schedule a clinical appointment with Dr. Dure

Please send an email with the subject line: Referral from FMM Re: Appointment with Dr. Dure for Mitochondrial Disease Patient to the following email address: (Note: Contact information regarding participation in bioenergetic research study will be released at later date). 


Stay connected with FMM 



Stay Connected with FMM

  • This field is for validation purposes and should be left unchanged.
Translate »